In your own time, hear George Lee discuss his work at Bristol-Myers Squibb, where they are using artificial intelligence to quantify the tumour microenvironment in histopathology images and to inform the best treatment options for patients considering immunotherapies.

Get the presentation in seconds. Fill in the form opposite.